ILC Therapeutics announces successful completion of £3.5m funding round
6 September, 2021
ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a ground-breaking new class of interferon drugs, announces the successful completion of a £3.5m pre-...more >